Sentences with phrase «by biopharmaceutical»

LONDON — Biopharmaceutical firm MediciNova Inc. will acquire Avigen Inc. for $ 1.24 a share in cash or secured convertible notes, under an agreement announced Friday by the biopharmaceutical firms.

This constitutes a major cause of long - term sick leave and forced early retirement, placing a great financial burden on both individuals and healthcare systems.Despite extensive research programmes by biopharmaceutical companies and academia, there remains a need for treatments that are more effective and with fewer side - effects.

The study is funded by the biopharmaceutical company Merck & Co., which makes pembrolizumab, or Keytruda.

In April 2011, TransMolecular's tumour - targeter was snapped up by biopharmaceutical company Morphotek, a US - based subsidiary of Japanese drug giant Eisai.

Proclara Biosciences Australia, a subsidiary of Proclara Biosciences, awarded grant by Biopharmaceuticals Australia to help develop new biotherapy with blockbuster potential March 10, 2017

Not exact matches

By merging, Babcook says, «we can increase our probability of becoming an anchor company for Canada and a fully integrated biopharmaceutical company over the long term.»

Of 12 major, large - cap biopharmaceutical companies examined by Deloitte, the industry appears to be homing in on cancer therapies — and for a good economic reason.

Prior to Sucampo, he served as Chief Scientific Officer of Ambrx Inc., a clinical - stage biopharmaceutical company focused on the development of antibody - drug conjugates (ADCs) that was acquired by a consortium led by Fosun Pharmaceutical Group in 2015.

Biopharmaceutical company Parexel confirmed Tuesday morning it will be acquired by Pamplona Capital for $ 88.10 per share in cash, in a transaction valued at approximately $ 5 billion.

Biopharmaceutical treatments, led by haemophilia, make up around 20 percent of Novo's sales, with diabetes and obesity products accounting for the remaining 80 percent.

Both Price and Gottlieb were questioned on their intimate involvement with biopharmaceutical and health care companies by lawmakers; Price specifically was the subject of sharp ethics questions about his financial investments in medical firms that would also benefit from legislation he was pushing while serving in the House of Representatives.

Retailer Williams - Sonoma, biopharmaceutical company Medivation and bank Wells Fargo ranked as the companies with the most high - ranking positions held by women, researchers said.

Wth technology addressing skin microbial therapeutics, fertility science, chronic disease alleviation, post traumatic stress disorder treatments, and services for the biopharmaceutical and clinical research industries; the startups selected by Illumina will have access to the company's genomics and sequencing expertise, business coaching, lab and office space and an infusion of capital.

SOUTH SAN FRANCISCO, CA — July 25, 2017 — Kezar Life Sciences, a private, clinical - stage biopharmaceutical company developing novel small molecule therapeutics targeting the immunoproteasome and the protein secretion pathway, announced today that it has closed an oversubscribed Series B investment round of $ 50 million led by Cormorant Asset Management and Morningside Venture.

According to research by the Pharmaceutical Research and Manufacturers of America, the biotechnology and biopharmaceutical industries provide more than 850,000 direct jobs, contributing more than $ 1.2 trillion in economic output in the United States alone.

An online survey conducted by the Clinical Data Interchange Standards Consortium (CDISC) and CenterWatch1 with 750 respondents — including investigative site personnel (355), biopharmaceutical companies (211), service providers for the industry (146), and technology providers (38)-- yielded the following results:

It was sponsored by Navidea Biopharmaceuticals.

Ethical concerns After two infected Americans were treated with a cocktail of antibodies made by Mapp Biopharmaceutical of San Diego, California, three UK - based international health experts called on 5 August for such drugs to be made available to Africans.

Now a portable production system, designed to manufacture a range of biopharmaceuticals on demand, has been developed by researchers at MIT, with funding from the Defense Advanced Research Projects Agency (DARPA).

«Since it's impossible to predict which of these agents will cause the next epidemic, it would be ideal to develop a single therapy that could treat or prevent infection caused by any known ebolavirus,» says study co-leader Zachary A. Bornholdt, Ph.D., director of antibody discovery at Mapp Biopharmaceutical, Inc. «Our discovery and characterization of broadly neutralizing human antibodies is an important step toward that goal,» adds study co-leader, Kartik Chandran, Ph.D., professor of microbiology & immunology at Albert Einstein College of Medicine.

In Texas the Ebola patient is now stable but in critical condition and being treated with brincidofovir, an oral medicine developed by Durham, N.C. — based biopharmaceutical company, Chimerix.

The conditions of two Americans have reportedly improved since they received a highly experimental antibody cocktail called ZMapp, supplied by San Diego - based Mapp Biopharmaceutical.

Made by Mapp Biopharmaceutical of San Diego, California, ZMapp contains three monoclonal antibodies produced in tobacco plants.

iBET's infrastructure comprises 16 laboratories fully equipped with state - of - the - art technology (70 m2 each), including a BSL2 laboratory for working with viruses; a GMP Analytical Services Unit certified by the INFARMED (the Portuguese medicines authority, EMA Portuguese branch) and by DGAV (the Portuguese veterinary authority) for quality control and batch release of human and veterinary pharmaceuticals, biopharmaceuticals as well as experimental new drugs; a GMP Mass - Spectroscopy Unit that provides state - of - the - art MS services to the scientific community and Industry; a 2600 m2 bio-pilot plant supporting production and purification of proteins ATMPs and vaccines from bench top to 300 L scale and privileged access to GeniBET Biopharmaceuticals, an iBET spin - off producing ATMPs under cGMP certification for phase I / II / IIbiopharmaceuticals as well as experimental new drugs; a GMP Mass - Spectroscopy Unit that provides state - of - the - art MS services to the scientific community and Industry; a 2600 m2 bio-pilot plant supporting production and purification of proteins ATMPs and vaccines from bench top to 300 L scale and privileged access to GeniBET Biopharmaceuticals, an iBET spin - off producing ATMPs under cGMP certification for phase I / II / IIBiopharmaceuticals, an iBET spin - off producing ATMPs under cGMP certification for phase I / II / III clinical trials.

Since the initial Michigan trial, the liposomal transport system — developed by researchers at Vical, a San Diego - based biopharmaceutical company interested in gene therapy — has been altered in ways that are expected to make it safer, more effective and easier to administer.

Here, we address that unmet need for cell therapy biomanufacturing, in part by leveraging existing decision - engineering frameworks for biopharmaceuticals to build on the nascent body of published work geared towards cell therapies.

The higher production efficiencies gained by ALiCE ™ will make it possible for biopharmaceutical researchers to detect a significantly higher number of candidates from each DNA library screened, eventually leading to a higher number of viable candidates for development.

GMP Analytical Services Unit certified by the INFARMED (the Portuguese medicines authority, EMA Portuguese branch) and by DGAV (the Portuguese veterinary authority) for quality control and batch release of human and veterinary pharmaceuticals, biopharmaceuticals as well as experimental new drugs.

Recently, iBET became the coordinator of a research unit funded by FCT, iNOVA4Health, a translational medicine program organising the efforts of biomedical researchers involved in biological understanding of disease, lead compounds and biopharmaceuticals «pre-discovery», technological scientists involved in «preclinical development», and clinicians involved in «early clinical and first in man clinical trials» from institutions within NOVA University of Lisbon.

Starting operations in 2012, iTeos Therapeutics is a clinical - stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by developing immunotherapies by design.

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc..

Press Release: Shire pays $ 825m to develop Renovo's scar - reduction remedy By Karen Attwood Thursday, 21 June 2007 Share Shire is to pay up to $ 825m (# 414m) to Renovo for the exclusive development and commercialisation rights to the biopharmaceutical company's groundbreaking scar - prevention drug.

SAN DIEGO and ALAMEDA, Calif., June 25, 2009 (GLOBE NEWSWIRE)-- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq: MNOV — News) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), and Avigen, Inc. (Nasdaq: AVGN — News), a biopharmaceutical company, today announced that they have confirmed their understanding of certain key terms for a proposed acquisition of Avigen by MediciNova that would combine the companies» broad neurological clinical development programs based on ibudilast (Avigen's AV - 411 and MediciNova's MN - 166).

Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.

FTSE 100 biopharmaceutical company Shire, led by director of legal strategy Claire Debney (pictured top left) and legal strategy manager Ama Zbarcea, has conducted an extensive sandbox exercise to engage its staff in the selection of a contract management system, as part of a much wider technologyled transformation programme.

Shire's CSO leads tech transformation programme FTSE 100 biopharmaceutical company Shire, led by chief strategy officer Claire Debney and legal strategy manager Ama Zbarcea, has conducted an extensive sandbox exercise to engage its staff in the selection of a contract management system, as part of a much wider technology - led transformation programme.

With a eight years of research & development experience in molecular biology and biochemistry, I desire to develop a career in biopharmaceutical industry by using my technical, scientific, leadership, problem solving and management skills to carry out lab bench work that meet the business goals of a cutting edge company.